Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

"Cannabis companies with the lowest costs of capital are best positioned to survive"

Roundhill Investments has re-focused the exposure of its Roundhill Cannabis ETF to exclusively target the largest and most-liquid U.S. multi-state operators ("MSOs"). In addition, Roundhill has agreed to lower the WEED ETF's net expense ratio to 0.39% until at least April 30, 2023. Based on the fee waiver, WEED is now the lowest-cost cannabis ETF globally.

Due to current macroeconomic conditions, including high-interest rates and persistent inflation, Roundhill believes that the cannabis companies with the lowest costs of capital and strongest relative balance sheets are best positioned to survive a downturn and increase market share. Tier 1 MSOs, defined as U.S. cannabis companies generating in excess of $500 million in annual revenues, most closely align with this view.

As of October 11, 2022, the WEED ETF maintained concentrated economic exposure to six MSOs: Curaleaf Holdings (34.5% weight), Green Thumb Industries (20.3% weight), Trulieve Cannabis (17.2% weight), Verano Holdings (14.4% weight), Cresco Labs (8.7% weight), and Columbia Care (4.2% weight).

For more information:
Roundhill Investments 
www.roundhillinvestments.com 



Publication date: